Predictive Oncology Inc (POAI)
Official siteHEALTH INFORMATION SERVICES
Last updated: Nov 16, 2026 at 4:00 PM ET
Predictive Oncology Inc (POAI) Stock Chart
Predictive Oncology (POAI) closed at $7.32 on Nov 16, 2026. Its price rose 12.6% over the past 12 months. The month-end price fell 99.8% since Jan 2018, a compound annual decline of 51.0%.
Price Chart
From Jan 2018 to Oct 2026, its highest month-end close was $4,077.96 in Jan 2018 and its lowest $1.62 in Mar 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart POAI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for POAI.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 29.1%, and over 6 months it rose 56.4%. The month-end price fell 82.2% over the 3 years through Oct 2026, a compound annual decline of 43.8%.
| Period | Change |
|---|---|
| 1 month | -4.7% |
| 3 months | -29.1% |
| 6 months | +56.4% |
| 12 months | +12.6% |
| 12 months, with dividends | +12.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -82.2% | -43.8% |
| 5 years | -97.9% | -53.7% |
| Since Jan 2018 | -99.8% | -51.0% |
Price by Year
Its best calendar year was 2021, when the price rose 30.0%, and its weakest was 2024, when it fell 75.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $8.00 | +11.9% |
| 2025 | $7.15 | -41.8% |
| 2024 | $12.29 | -75.1% |
| 2023 | $49.33 | -46.3% |
| 2022 | $91.93 | -67.8% |
| 2021 | $285.43 | +30.0% |
| 2020 | $219.61 | -71.9% |
| 2019 | $782.61 | -57.8% |
Trading Range
The price is 25.7% below its 50-day average of $9.85 and 8.5% above its 200-day average of $6.75.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $7.32 | |
| 50-day average | $9.85 | -25.7% |
| 200-day average | $6.75 | +8.5% |
Price Risk
Over 3 years, its largest fall from a peak was 97.4%.
| Measure | Value |
|---|---|
| 1-year beta | 3.67 |
| Largest fall, 1 year | -80.8% |
| Largest fall, 3 years | -97.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About POAI
What is POAI's 1-year price change?
Predictive Oncology's price rose 12.6% over the past 12 months. With dividends included, the 12-month total return was 12.6%.
What is POAI's 5-year price change?
Predictive Oncology's month-end price fell 97.9% over the 5 years through Oct 2026, a compound annual decline of 53.7%. These figures leave out dividends.
What is POAI's beta?
Predictive Oncology's 1-year beta against the S&P 500 is 3.67, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 80.8%.
Is the POAI chart free?
Yes. Advanced Charting for POAI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
POAI pages: Overview, Charting, Financials